Evidence map›Paper›PMID 38057577›Full record

ArticlePediatric research2024

Neurodevelopmental assessment of normocephalic children born to Zika virus exposed and unexposed pregnant people.

Jackeline Alger, María Luisa Cafferata, Raquel López, Lisa D Wiggins, Allison Callejas, Mario Castillo, Jenny Fúnes, Fátima Rico, Diana Valencia, Douglas Varela and 28 more

Open access · greenAbstract read
In one paragraph

Article in Pediatric research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. A Review of the Recent Epidemiology of Zika Virus Infection.The American journal of tropical medicine and hygiene · 2025
    Review
  6. Article
  7. Flaviviruses-Induced Neurological Sequelae.Pathogens (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 7 institutions in 4 countries.

Jackeline Alger *Instituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras. jackelinealger@gmail.com.ORCID 0000-0001-9244-0668
María Luisa Cafferata *Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina. marialuisa.cafferata@gmail.com.
Raquel LópezInstituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras.
Lisa D WigginsNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Allison CallejasServicio de Neonatología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Mario CastilloServicio de Neonatología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Jenny FúnesServicio de Neonatología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Fátima RicoDepartamento de Pediatría, Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Diana ValenciaNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Douglas VarelaServicio de Neurología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Zulma AlvarezUnidad de Vigilancia de la Salud, Región Sanitaria Metropolitana del Distrito Central, Secretaría de Salud de Honduras, Tegucigalpa, Honduras.
Mabel BerruetaInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Harry BockDirección General, Región Sanitaria Metropolitana del Distrito Central, currently Centro de Salud Dra. Nerza Paz, Región Sanitaria Metropolitana del Distrito Central, Secretaría de Salud de Honduras, Tegucigalpa, Honduras.
Carolina BustilloDepartamento de Ginecología y Obstetricia, Hospital Escuela, Tegucigalpa, Honduras.
Alejandra CalderónCentro de Salud Alonso Suazo, Región Sanitaria Metropolitana del Distrito Central, currently Centro de Salud Villanueva, Región Sanitaria Metropolitana del Distrito Central, Secretaría de Salud de Honduras, Tegucigalpa, Honduras.
Alvaro CigandaInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Jorge García-AguilarInstituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras.
Kimberly GarcíaCentro de Investigaciones Genéticas, Instituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Luz GibbonsInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Suzanne M GilboaNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Emily W HarvilleDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Gustavo HernándezDepartamento de Pediatría, Hospital de Especialidades San Felipe, Tegucigalpa, Honduras.
Wendy LópezInstituto de Enfermedades Infecciosas y Parasitología Antonio Vidal, Tegucigalpa, Honduras.
Ivette LorenzanaCentro de Investigaciones Genéticas, Instituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Marco T LuqueServicio de Infectología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Carlos MaldonadoServicio de Oftalmología, Departamento de Pediatría, Hospital Escuela, Tegucigalpa, Honduras.
Cynthia MooreGoldbelt Professional Services, LLC, Chesapeake, VA, USA.
Carlos OchoaServicio de Maternidad, Hospital de Especialidades San Felipe, Tegucigalpa, Honduras.
Leda ParhamCentro de Investigaciones Genéticas, Instituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Karla PastranaDepartamento de Ginecología y Obstetricia, Hospital Escuela, Tegucigalpa, Honduras.
Angel Paternina-CaicedoDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Heriberto RodríguezDepartamento de Ginecología y Obstetricia, Hospital Escuela, Tegucigalpa, Honduras.
Candela StellaInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
Ayzsa F TannisEagle Global Scientific, LLC, San Antonio, TX, USA.
Dawn M WessonDepartment of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Concepción ZúnigaDepartamento de Vigilancia de la Salud, Hospital Escuela, Tegucigalpa, Honduras.
Van T TongNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pierre BuekensDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Universidad Metropolitana de Honduras · HNInstituto de Efectividad Clínica y Sanitaria · ARCenters for Disease Control and Prevention · USNational Autonomous University of Honduras · HNTulane University · USSecretaria de Salud · HNInstituto de Investigación de Enfermedades Raras · ES

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundStudies examining the association between in utero Zika virus (ZIKV) exposure and child neurodevelopmental outcomes have produced varied results.

methodsWe aimed to assess neurodevelopmental outcomes among normocephalic children born from pregnant people enrolled in the Zika in Pregnancy in Honduras (ZIPH) cohort study, July-December 2016. Enrollment occurred during the first prenatal visit. Exposure was defined as prenatal ZIKV IgM and/or ZIKV RNA result at enrollment. Normocephalic children, >6 months old, were selected for longitudinal follow-up using the Bayley Scales of Infant and Toddler Development (BSID-III) and the Ages & Stages Questionnaires: Social-Emotional (ASQ:SE-2).

resultsOne hundred fifty-two children were assessed; after exclusion, 60 were exposed and 72 were unexposed to ZIKV during pregnancy. Twenty children in the exposed group and 21 children in the unexposed group had a composite score <85 in any of the BSID-III domains. Although exposed children had lower cognitive and language scores, differences were not statistically significant. For ASQ:SE-2 assessment, there were not statistically significant differences between groups.

conclusionsThis study found no statistically significant differences in the neurodevelopment of normocephalic children between in utero ZIKV exposed and unexposed. Nevertheless, long-term monitoring of children with in utero ZIKV exposure is warranted. IMPACT: This study found no statistically significant differences in the neurodevelopment in normocephalic children with in utero Zika virus exposure compared to unexposed children, although the exposed group showed lower cognitive and language scores that persisted after adjustment by maternal age and education and after excluding children born preterm and low birth weight from the analysis. Children with prenatal Zika virus exposure, including those normocephalic and have no evidence of abnormalities at birth, should be monitored for neurodevelopmental delays. Follow-up is important to be able to detect developmental abnormalities that might not be detected earlier in life.

Indexed as

CraniosynostosesPregnancy Complications, InfectiousPrenatal Exposure Delayed EffectsZika VirusZika Virus InfectionChild DevelopmentCohort StudiesFemaleHumansInfantInfant, NewbornPregnancy

Identifiers

PMID38057577
PMCPMC11045253
OpenAlexW4389377833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.